| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RENOVARO BIOSCIENCES INC. | COO and Executive VP for R&D | Option to Purchase Common Stock | 40,000 | 13 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RENB | RENOVARO BIOSCIENCES INC. | 13 Feb 2024 | 6 | $0 | 4 | COO and Executive VP for R&D | 16 Feb 2024, 09:44 |
| RENB | Enochian Biosciences Inc | 18 Oct 2022 | 1 | $0 | 4 | Executive VP for R&D | 27 Oct 2022, 16:54 |
| RENB | RENOVARO BIOSCIENCES INC. | 22 Jul 2022 | 0 | $0 | 3/A | COO and Executive VP for R&D | 16 Feb 2024, 09:38 |
| RENB | Enochian Biosciences Inc | 22 Jul 2022 | 0 | $0 | 3 | Executive Vice President | 18 Aug 2022, 12:41 |